We are now seeing more and more generics for “extended-release” drugs, i.e., diltiazem XT, metformin ER, and others. Can we rely on these to be pharmacokinetically equivalent to the original ...
The U.S. Food and Drug Administration (FDA) has announced a significant update to the labeling of all extended-release medications used to treat Attention-Deficit ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback